Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A

Tyrosine kinase inhibitors in the treatment of systemic mastocytosis

(2011) Celalettin Ustun et al.   LEUKEMIA RESEARCH

A novel FcεRIβ-chain truncation regulates human mast cell proliferation and survival

(2010) Glenn Cruse et al.   FASEB JOURNAL

Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis

(2010) T. M. Wilson et al.   HAEMATOLOGICA

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

(2009) J. W. Friedberg et al.   BLOOD

Proteomic and Genetic Approaches Identify Syk as an AML Target

(2009) Cynthia K. Hahn et al.   CANCER CELL

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

(2009) A Tefferi et al.   LEUKEMIA

Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes

(2009) Chunaram Choudhary et al.   MOLECULAR CELL